MSG Annual Meeting Archives

2008 MSG Annual Meeting

The MSG held a meeting of clinical scientists on September 15-17, 2008 at Beaver Hollow, Java Center, NY entitled “Experimental Therapeutics of Neuromuscular Disease”. The conference brought together translational and clinical scientists in a forum for discussion of current and novel therapies and drew speakers and participation from international experts with an interest in developing international collaborations between trainees and investigators focused on clinical trials. Specific to international collaboration many members of the TREAT-NMD consortium based in Europe attended the meeting thereby fostering connections necessary to facilitate clinical trials in the rare diseases.

The agenda included two major sessions: (1) Novel designs and outcome measures in translational neuromuscular research and (2)  scientific updates in basic science, methods and treatment strategies.

This meeting was sponsored by:

Presentations for which approval was received to post on the internet are below:

Ocular MG –Michael Benatar 

Sleuthing Targets for Disease in Muscle - Andrew Engel

Clinical Investigation of Neurological Channelopathies
(CINCH) Landmarks - Robert C. Griggs

HYP HOP - Robert C. Griggs

Clinical Trials: From Inception to Implementation - Laura Herbelin

Trial Iimplementation Strategies - Cornelia Kamp

Clinical Materials Services Unit (CMSU) - Cornelia Kamp

Iplex Treatment of Myotonic Dystrophy - Richard T. Moxley, III

High Dose Ascorbic Acid to Treat CMT1A –Michael Shy

 

MSG 2007Annual Meeting

Through the funding of a NIH R13 award the MSG held a meeting of clinical scientists on September 17-19, 2007 at Beaver Hollow, Java Center, NY. The program emphasized translational approaches to bringing molecular discoveries into well-designed clinical studies.

The agenda included two major sessions: (1) Novel designs and outcome measures in translational neuromuscular research and (2)  scientific updates in basic science, methods and treatment strategies.

 

MSG 2006 Annual Meeting

Through the funding of a NIH R13 award MSG held a meeting of clinical scientists on May 31 - June 2, 2006 at Beaver Hollow, Java Center, NY. The program emphasized translational and experimental therapeutics research.

The agendaand included two major sessions: (1) Translational bench-to-bedside presentations on topics including muscular dystrophy, neuromuscular junction disorders and motor neuron disorders and (2) Clinical trial methodology session including industry, FDA and academic perspectives.